phrykt

Clarivate Plc (CLVT): who owns it and who trades it

As of Nov 16, 2026, CLVT insiders reported 4 open-market sales worth $6M and 2 purchases worth $1.7M in the last 12 months, with 19% of the sale value made under pre-set 10b5-1 plans. The largest seller was Andrew Miles Snyder (Director), with $4.8M. 4 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling Clarivate

From the latest filings

Overall: more buying than selling. Insiders mostly sold. Famous investors mostly bought. Funds was close to even.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Who owns CLVT

241 funds and institutions reported CLVT shares worth $1.3B at the end of Q2 2026, about 92% of the company. The largest holder is Leonard Green & Partners, L.P. with 18.2%.

Funds and institutions (13F) 92%Everyone else 8%

10 largest owners, by share of the company

Leonard Green & Partners, L.P.18.2%
Exor N.V.10.5%
Clarkston Capital Partners, LLC7.1%
BlackRock, Inc.4.9%
Partners Group Holding AG4.0%
FIL Ltd3.9%
Dimensional Fund Advisors LP3.0%
Edmond DE Rothschild Holding S.a.2.5%
Citadel Advisors LLC2.3%
American Century Companies Inc2.2%

Top 20 owners

OwnerShares% of companyValueChange since Q1 2026
Leonard Green & Partners, L.P.116.67M18.24%$252MNo change
Exor N.V.67.29M10.52%$145MNo change
Clarkston Capital Partners, LLC45.73M7.15%$98.8M+7%
BlackRock, Inc.31.15M4.87%$67.3M+48%
Partners Group Holding AG25.58M4.00%$55.3MNo change
FIL Ltd25.27M3.95%$54.6MNo change
Dimensional Fund Advisors LP19.07M2.98%$41.2M-6%
Edmond DE Rothschild Holding S.a.16.22M2.54%$35M-9%
Citadel Advisors LLC14.63M2.29%$31.6M-17%
American Century Companies Inc14.27M2.23%$30.8M+15%
Invenomic Capital Management LP14.26M2.23%$30.8M+7%
First Trust Advisors LP13.54M2.12%$29.2M+145%
Atairos Group, Inc.12.26M1.92%$26.5MNo change
Thompson Siegel & Walmsley LLC10.93M1.71%$23.6M-24%
State Street Corp10.86M1.70%$23.5M+45%
Atairos Partners GP, Inc.10.23M1.60%$22.1MNo change
Geode Capital Management, LLC10.08M1.58%$21.8M+43%
AustralianSuper Pty Ltd10.07M1.57%$21.8MNo change
BW Gestao de Investimentos Ltda.10.04M1.57%$21.7M+70%
Prudential Financial Inc8.06M1.26%$17.4M-26%

From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.

Insider trades

In the last 12 months, CLVT insiders reported $1.7M of open-market purchases and $6M of sales. 19% of the sale value was under a 10b5-1 plan, a schedule set up in advance.

Purchases, 12 months
$1.7M
2 trades, 1 people
Sales, 12 months
$6M
4 trades, 2 people
Sales under a 10b5-1 plan
19%
Share of sale value
Latest trade
Aug 7, 2026
Filed Aug 10, 2026

Purchases and sales by month

$4.8M$4.8MDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Aug 7, 2026Kenneth L. CornickDirectorPurchase250,000$1.85$462KForm 4
Aug 6, 2026Kenneth L. CornickDirectorPurchase650,000$1.86$1.2MForm 4
Aug 3, 2026Andrew Miles SnyderDirectorSale176,674$1.94$343KForm 4
Aug 3, 2026Andrew Miles SnyderDirectorSale310,702$1.94$603KForm 4
Aug 3, 2026Andrew Miles SnyderDirectorSale2.00M$1.94$3.9MForm 4
Dec 1, 2025Bar VeinsteinPresidentSale plan309,902$3.74$1.2MForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
Andrew Miles SnyderDirector–$4.8MAug 3, 2026
Kenneth L. CornickDirector$1.7M–Aug 7, 2026
Bar VeinsteinPresident, A&G–$1.2MDec 1, 2025
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

CLVT short interest

Moderate short interest. 7.6% of CLVT shares are sold short: about 1 share in 13. Over the last 12 reports the number of shares short went down 14%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 48.43M CLVT shares were sold short, 7.6% of the shares outstanding, up 3.5% from the report before. At the average daily volume of 3.51M shares, buying them all back would take about 13.8 trading days (days to cover).

Shares short, % of all shares

7.57%May 15Oct 3010.0%

Days to cover

13.8May 15Oct 3015.0

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 202648.43M7.57%+4%3.51M13.8
Oct 15, 202646.78M7.31%-3%3.56M13.1
Sep 30, 202648.18M7.53%-1%4.55M10.6
Sep 15, 202648.44M7.57%-2%4.20M11.5
Aug 31, 202649.51M7.74%-3%4.06M12.2
Aug 14, 202651.03M7.98%-3%4.89M10.4
Jul 31, 202652.79M8.25%-5%5.97M8.8
Jul 15, 202655.38M8.66%-10%9.29M6.0
Jun 30, 202661.74M9.65%+18%10.88M5.7
Jun 15, 202652.48M8.21%-1%5.02M10.5
May 29, 202652.86M8.27%-6%4.61M11.5
May 15, 202656.26M8.80%+2%5.09M11.1

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Clarivate company events

Clarivate filed 19 reports on Form 8-K in the last 12 months, 5 of them about an important change (leadership). The latest was on Nov 10, 2026.

  1. Nov 10, 2026AnnouncementClarivate Plc issued a press release announcing the pricing terms of the previously announced cash tender offers by its wholly-owned subsidiary, Clarivate Science Holdings Corporation, for certain of its debt securities. Filing
  2. Nov 4, 2026AnnouncementClarivate Plc issued a press release announcing the launch of cash tender offers by its wholly-owned subsidiary, Clarivate Science Holdings Corporation, for certain of its debt securities. Filing
  3. Nov 3, 2026ResultsReleased financial results. Filing
  4. Oct 13, 2026DealAmended an earlier report. Clarivate Plc filed a Current Report on Form 8-K to disclose that, among other things, the previously announced sale of its Life Sciences and Healthcare business was completed on October 6, 2026. Filing
  5. Oct 6, 2026LeadershipUpon the Closing and in connection with the Transaction, Henry Levy, Clarivate’s President, Life Sciences & Healthcare, terminated employment with a subsidiary of Clarivate. Filing
  6. Sep 24, 2026AnnouncementClarivate Plc issued a press release announcing the expiration and results of the previously announced cash tender offer by its wholly-owned subsidiary, Clarivate Science Holdings Corporation, for certain of its debt securities. Filing
  7. Sep 23, 2026AnnouncementClarivate Plc issued a press release announcing the pricing terms of the previously announced cash tender offer by its wholly-owned subsidiary, Clarivate Science Holdings Corporation, for certain of its debt securities. Filing
  8. Sep 17, 2026AnnouncementClarivate Plc issued a press release announcing the launch of cash tender offer by its wholly-owned subsidiary, Clarivate Science Holdings Corporation, for certain of its debt securities. Filing
  9. Jul 29, 2026LeadershipJonathan Collins, the Executive Vice President & Chief Financial Officer of Clarivate Plc resigned from his position, effective August 7, 2026. Filing
  10. Jul 29, 2026ResultsReleased financial results. Filing
  11. Jul 6, 2026LeadershipA subsidiary of Clarivate entered into a retention agreement with Henry Levy, Clarivate’s President, Life Sciences & Healthcare, to encourage his continued commitment toward the completion of the Transaction. Filing
  12. Jul 6, 2026AnnouncementShared information with investors. Filing
  13. Jun 8, 2026LeadershipMaroun S. Mourad, President, Intellectual Property of Clarivate Plc will depart from his position, effective June 9, 2026. Filing
  14. May 18, 2026AnnouncementDate of 2027 Annual General Meeting of Shareholders Clarivate’s 2027 Annual General Meeting of Shareholders will be held on May 6, 2027. Filing
  15. Apr 29, 2026ResultsReleased financial results. Filing
  16. Mar 26, 2026LeadershipThe Board of Directors of Clarivate Plc, upon the recommendation of the Human Resources and Compensation Committee of the Board, approved the adoption of the Amended and Restated Executive Severance Plan of Clarivate Plc, effective March 23, 2026. Filing
  17. Feb 24, 2026ResultsReleased financial results. Filing
  18. Feb 3, 2026AnnouncementShared information with investors. Filing
  19. Feb 2, 2026AnnouncementBelow as to the satisfaction and discharge of the Indenture dated as of October 31, 2019 (as amended or supplemented to date, the “Indenture”) among Camelot Finance S.A., a subsidiary of Clarivate Plc, the guarantors named therein, and Wilmington Trust, National Association, as trustee and… Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

Clarivate financials

Famous investors that hold CLVT

4 of the 50 well-known investors we track reported holding CLVT in their latest 13F filing. The largest position is Ken Griffin's, worth $27.5M.

Position size

All holders

FundQuarterSharesValueOf portfolioChange
Ken Griffin · Citadel AdvisorsQ3 202616.46M$27.5M0.0%+13%
Steve Cohen · Point72 Asset ManagementQ3 2026776,471$1.3M0.0%New
Jim Simons · Renaissance TechnologiesQ3 2026659,284$1.1M0.0%+209%
Israel Englander · Millennium ManagementQ3 202645,169$75.4K0.0%+287%

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

Questions about Clarivate Plc (CLVT) stock

Who owns the most CLVT stock?

The largest reported owner of Clarivate Plc (CLVT) is Leonard Green & Partners, L.P., with 18.2% of the company. In total, 241 funds and institutions reported holding CLVT at the end of Q2 2026, together about 92% of the shares. See the largest owners.

Are CLVT insiders buying or selling?

In the last 12 months, CLVT insiders reported 2 open-market purchases worth $1.7M and 4 sales worth $6M. The latest trade was on Aug 7, 2026. See every trade.

What is the short interest in CLVT?

As of Oct 30, 2026, 48.43M CLVT shares were sold short, 7.6% of the shares outstanding, up 3.5% from the report before. At the average daily volume of 3.51M shares, buying them all back would take about 13.8 trading days (days to cover). See the history.

Which famous investors hold CLVT?

4 of the 50 well-known investors we track reported CLVT in their latest 13F filing, including Ken Griffin, Steve Cohen, Jim Simons. The largest position is worth $27.5M. See all holders.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.